Research Article

Predictors of mortality among people living with HIV in the test and treat era within rural Uganda: a retrospective cohort study

Published in: African Journal of AIDS Research
Volume 21 , issue 3 , 2022 , pages: 231–238

DOI: 10.2989/16085906.2022.2056062

Author(s): Anacret Byamukama , Uganda , Pauline M Golding , United Kingdom

Keywords: highly active antiretroviral therapy , human immunodeficiency virus , non-nucleoside reverse transcriptase inhibitor , nucleoside reverse transcriptase inhibitor

Download full text Get new issue alerts

Abstract

Background: Uganda adopted the test and treat strategy in 2016 where all people living with HIV are initiated on antiretroviral drugs irrespective of CD4 count and WHO clinical stage, as one of the major strategies to end the HIV epidemic by 2030. Despite these measures, there are still more than 2 000 HIV-related death annually. The study aim was to determine the mortality rate and factors predictive of mortality in the test and treat era among people living with HIV in rural Uganda.

« “I didn’t support PrEP because I didn’t know what it was”: Inadequate information undermines male partner support for young women’s pre-exposure prophylaxis use in western Kenya

Exploring how outreach team leaders perceive community health workers’ experiences of providing HIV services in KwaZulu-Natal, South Africa »